A Pilot Study on the Effect of Privigen Against Graft Loss: Interventional Study of Kidney Transplant Recipients at Risk for Graft Loss Through Antibody-mediated Rejection

Trial Profile

A Pilot Study on the Effect of Privigen Against Graft Loss: Interventional Study of Kidney Transplant Recipients at Risk for Graft Loss Through Antibody-mediated Rejection

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms InAuGuRAL
  • Most Recent Events

    • 12 May 2016 Last checked against ClinicalTrials.gov record.
    • 09 May 2016 Planned End Date changed from 1 Mar 2017 to 1 Feb 2019.
    • 09 May 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Feb 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top